ONYX PHARMACEUTICALS INC: eps_basic
| Value | {"per": "shares", "amount": -2.25, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-09-30 |
| Status | current |
| Entity | ONYX PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/69b5977f-7bfe-4d36-b595-9ceeb35e839f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-12-073762 · Open the official SEC filing →Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001012140/eps-basic/2012-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/69b5977f-7bfe-4d36-b595-9ceeb35e839f
History
- no predecessors — first report